GLP-1 pre­scrip­tions reach all-time high as Lil­ly and No­vo scram­ble to keep pace with de­mand

More US pa­tients than ever are be­ing pre­scribed GLP-1 weight loss med­ica­tions each week, and bio­phar­ma ex­perts have in­creased their an­nu­al sales fore­casts of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.